BE756953A - Potentialisation d'antibiotiques - Google Patents

Potentialisation d'antibiotiques

Info

Publication number
BE756953A
BE756953A BE756953DA BE756953A BE 756953 A BE756953 A BE 756953A BE 756953D A BE756953D A BE 756953DA BE 756953 A BE756953 A BE 756953A
Authority
BE
Belgium
Prior art keywords
potentialization
antibiotics
Prior art date
Application number
Other languages
English (en)
French (fr)
Inventor
F M Kahanet P J Cassidy
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE756953A publication Critical patent/BE756953A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE756953D 1969-10-02 Potentialisation d'antibiotiques BE756953A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86335169A 1969-10-02 1969-10-02
US7124770A 1970-09-11 1970-09-11

Publications (1)

Publication Number Publication Date
BE756953A true BE756953A (fr) 1971-04-01

Family

ID=26752007

Family Applications (1)

Application Number Title Priority Date Filing Date
BE756953D BE756953A (fr) 1969-10-02 Potentialisation d'antibiotiques

Country Status (7)

Country Link
BE (1) BE756953A (enExample)
CA (1) CA943067A (enExample)
DE (1) DE2048375A1 (enExample)
FR (1) FR2070104B1 (enExample)
GB (1) GB1311956A (enExample)
IL (1) IL35334A (enExample)
NL (1) NL7014541A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660305A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
CH660306A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
RS20050532A (sr) 2003-01-14 2007-12-31 Arena Pharmaceuticals Inc., Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１ｐ１受容体に関連する状態を治療する方法

Also Published As

Publication number Publication date
FR2070104A1 (enExample) 1971-09-10
NL7014541A (enExample) 1971-04-06
FR2070104B1 (enExample) 1974-02-22
CA943067A (en) 1974-03-05
GB1311956A (en) 1973-03-28
IL35334A0 (en) 1971-04-28
IL35334A (en) 1974-01-14
DE2048375A1 (de) 1971-04-22

Similar Documents

Publication Publication Date Title
AR192602A1 (es) Preparacion de aza-8 purinonas-6 sustituidas en 2
BE754856A (fr) Nouveaux antibiotiques
FI54314B (fi) Foerfarande foer framstaellning av pyrimidin- och 6-azapyrimidinnukleosider
BE748404A (fr) Compositions de polyols
BE750291A (fr) Structure d'orifice
IL35334A0 (en) Potentiation of phosphonomycin antibiotics
BE746575A (fr) Compositions stabilisees de polypropylene-polyvinylpyridine
IT988365B (it) Composizione di sciampo
BE760034A (fr) Production d'esters
BE749006A (fr) Preparation de polyalcenameres
BE754141A (fr) Esters d'alpha-carboxyarylmethyl penicillines
BE787236A (fr) Compositions de potentialisation
BE756360A (fr) Preparation continue de cyclohexanonoxime
BE752137R (fr) Production de
IT954108B (it) Composizione di sciampo
BE754650A (fr) Preparation d'alcenylalcoxysilanes
BE753574R (fr) Preparation de solutions de
BE750555A (fr) Preparation de mercaptans
BE758911A (fr) Preparation d'alpha-aminonitriles aromatiques
BE749790A (fr) Preparation de di-lithio(perfluoroalcoylethylsilyl) neocarboranes
BE755833A (fr) Badernes rotatives d'etrave
BE753379A (fr) Preparation de lysergols
BE771936A (fr) Preparation d'alpha-dithiols
BE749066A (fr) Preparation de propadienyl-17 alpha -steroides
BE758866A (fr) Macropolyesters d'acides phenylindane-dicarboxyliques